Tuesday, April 17, 2018
FDA.gov-9 hours ago
It advances a new effort to help more compounding pharmacies expand and grow their businesses. It promotes programs to modernize generic drug review as a way to increase competition and address high drug costs. And it advances new approaches to support the development of treatments for rare pediatric diseases.